Physician profile
Mohammad A Saeed
NPI 1831116383
$3,906.26
in general payments reported to CMS, 2019-2025
17 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,498 · 2020: $107 · 2021: $200 · 2022: $354 · 2023: $265 · 2024: $308 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,365.12 | 2019-2025 | Perclose Proglide, Gallant |
| Boston Scientific Corporation | $370.17 | 2019-2025 | Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $282.14 | 2021-2024 | Ellipsys Vascular Access System |
| Medtronic Vascular, INC. | $203.32 | 2019-2020 | |
| Philips North America LLC | $143.47 | 2019-2022 | |
| Nevro Corp. | $124.90 | 2024 | Senza |
| Neos Therapeutics, LP | $107.63 | 2022-2024 | Adzenys Xr-Odt |
| Surmodics, INC. | $47.98 | 2022 | |
| Stryker Corporation | $43.80 | 2025 | Limflow System |
| Globus Medical, INC. | $36.08 | 2025 | Senza |
| Janssen Pharmaceuticals, INC | $34.22 | 2019-2023 | Spravato |
| Mirum Pharmaceuticals, INC. | $33.88 | 2025 | Livmarli |
| Cardiovascular Systems INC. | $31.90 | 2021-2022 | |
| Penumbra, INC. | $23.31 | 2019 | |
| Shire North American Group INC | $22.51 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mozarc Medical US LLC | $19.02 | 2024 | Chameleon |
| Becton, Dickinson and Company | $16.81 | 2025 | Rotarexs 6 F X 135 Cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.